Published in J Clin Microbiol on August 01, 1987
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol (1986) 2.35
Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis (1981) 1.89
Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res (1980) 1.54
Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet Res (1984) 1.48
Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol (1987) 1.25
Competitive enzyme immunoassays for the rapid detection of antibodies to feline infectious peritonitis virus polypeptides. J Clin Microbiol (1985) 0.95
Role of recent vaccination in production of false-positive coronavirus antibody titers in cats. J Clin Microbiol (1984) 0.92
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet (1997) 6.34
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS (1997) 3.42
Sexual transmission of HIV: infectiousness and prevention. AIDS (1999) 2.59
Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS (1997) 2.51
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods (1996) 2.12
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08
Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J Virol (1997) 2.04
Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc Natl Acad Sci U S A (1980) 1.86
Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J Clin Microbiol (1994) 1.85
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS (1999) 1.76
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol (2000) 1.60
Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS (1998) 1.59
Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest (1975) 1.57
Structure of the mouse mammary tumor virus: polypeptides and glycoproteins. J Virol (1974) 1.56
A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer (1982) 1.47
Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis (1998) 1.42
Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS (1994) 1.38
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
Structure of the mouse mammary tumor virus: characterization of bald particles. J Virol (1974) 1.35
Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1999) 1.32
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden. J Infect Dis (1999) 1.32
HIV-1 viral load in blood, semen and saliva. AIDS (1997) 1.27
Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol (1987) 1.25
Serological and biochemical characterization of the mouse mammary tumor virus with localization of p10. Virology (1978) 1.22
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med (2001) 1.18
Type-specific antigenic determinants on the major external glycoprotein of high- and low-oncogenic murine mammary tumor viruses. J Virol (1977) 1.16
Radioimmunoassays that demonstrate type-specific and group-specific antigenic reactivities for the major internal structural protein of murine mammary tumor viruses. Cancer Res (1978) 1.15
Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. AIDS Res Hum Retroviruses (2005) 1.14
Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1. J Virol (1984) 1.12
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850). J Infect Dis (2000) 1.11
Characterization of mouse mammary tumor viruses propagated in heterologous cells. Cancer Res (1977) 1.11
Multiple antigenic determinants on the major surface glycoprotein of murine mammary tumor viruses. Proc Natl Acad Sci U S A (1977) 1.10
Interspecies radioimmunoassay for the major structural proteins of primate type-D retroviruses. Proc Natl Acad Sci U S A (1977) 1.10
Strain-specific markers for the major structural proteins of highly oncogenic murine mammary tumor viruses by tryptic peptide analyses. J Virol (1978) 1.08
Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count. J Infect Dis (1993) 1.06
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant. J Infect Dis (2001) 1.06
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis (1998) 1.04
Use of monoclonal antibodies to define the diversity of mammary tumor viral gene products in virions and mammary tumors of the genus Mus. Cancer Res (1981) 1.04
The structure of the mouse mammary tumor virus: isolation and characterization of the core. Virology (1977) 1.03
Two phases of HIV RNA decay in CSF during initial days of multidrug therapy. Neurology (2003) 1.00
Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 0.98
Competitive enzyme immunoassays for the rapid detection of antibodies to feline infectious peritonitis virus polypeptides. J Clin Microbiol (1985) 0.95
Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J Virol Methods (1996) 0.93
Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol (2001) 0.93
Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.91
Rapid detection of bovine herpesvirus type 1 antigens in nasal swab specimens with an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 0.91
Inhibition of HIV-1 by modification of a host membrane protease. Int Immunol (1995) 0.89
Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. J Dent Res (2001) 0.89
Limits on oral transmission of HIV-1. Lancet (2000) 0.89
Rational testing of the HIV-exposed infant. Pediatrics (2001) 0.88
Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res (1995) 0.88
Isolation and characterization of a new mouse mammary tumor virus from BALB/c mice. Virology (1981) 0.87
Characterization of a new virus from Mus cervicolor immunologically related to the mouse mammary tumor virus. J Natl Cancer Inst (1978) 0.86
Plasma HIV burden in Malawian children co-infected with rotavirus. AIDS (2001) 0.86
Noncoordinate expression of murine mammary tumor virus gene products. Virology (1980) 0.85
Shedding of HIV-1 in semen during primary infection. AIDS (1997) 0.84
Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil. J Infect Dis (1999) 0.84
Macrophages in efferent lymph of sheep and their role in lectin-induced lymphocyte blastogenesis. Int Arch Allergy Appl Immunol (1983) 0.84
Hormones, chemicals and proviral gene expression as contributing factors during mammary carcinogenesis in C3H/StWi mice. Int J Cancer (1981) 0.83
The use of lymphocytes from axillary lymph nodes of mastectomy patients to generate human monoclonal antibodies. Eur J Cancer Clin Oncol (1981) 0.83
Radioimmunoassays for the 36,000-dalton glycoprotein of murine mammary tumor viruses demonstrate type, group, and interspecies determinants. J Virol (1979) 0.82
Functional differences in the peplomer glycoproteins of feline coronavirus isolates. J Virol (1987) 0.82
Rapid detection of canine parvovirus in feces using monoclonal antibodies and enzyme-linked immunosorbent assay. Am J Vet Res (1984) 0.81
Comparison of enzyme-linked immunosorbent assay, DNA hybridization, hemagglutination, and electron microscopy for detection of canine parvovirus infections. J Clin Microbiol (1984) 0.80
The immunohistochemical reactivity of a human monoclonal antibody with tissue sections of human mammary tumors. Cancer (1982) 0.79
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases). J Clin Microbiol (1994) 0.79
Mitogen-induced blastogenesis of peripheral blood and efferent lymph lymphocytes from sheep. Am J Vet Res (1982) 0.79
Detection of novel murine mammary tumor viruses by interspecies immunoassays. J Natl Cancer Inst (1980) 0.79
Interspecies radioimmunoassay for the major internal protein of mammary tumor viruses. Virology (1980) 0.79
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group. J Clin Microbiol (1996) 0.77
Short courses of zidovudine and perinatal transmission of HIV. N Engl J Med (1999) 0.77
Functional and structural alterations of the nervous system induced by avian retrovirus RAV-7. Microb Pathog (1988) 0.77
Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid. J Clin Microbiol (2001) 0.76
Immunological and structural relationships between langur virus and other primate type-D retroviruses. Virology (1978) 0.76
Variation in mitogen-induced ovine lymphocyte blastogenesis: adherent cells or 2-mercaptoethanol restore randomly depressed responses. Vet Immunol Immunopathol (1982) 0.76
Immune activation and plasma viral load in HIV-infected African individuals. AIDS (1999) 0.75
Early detection of HIV in neonates. N Engl J Med (1993) 0.75
Chromium-51-release assay of antibody and complement-mediated cytotoxicity for contagious ecthyma virus-infected cells. Am J Vet Res (1978) 0.75
Rapid enzyme-linked immunosorbent assay for detecting antibodies to canine parvovirus. Am J Vet Res (1985) 0.75
Humoral immune response of cats to virulent and avirulent feline infectious peritonitis virus isolates. Adv Exp Med Biol (1987) 0.75
Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. J Natl Cancer Inst (1984) 0.75
Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapy. Lab Res Methods Biol Med (1983) 0.75
Immunological characterization of a mammary tumour virus from Swiss mice: multiple epitopes associated with the viral gene products. J Gen Virol (1981) 0.75
Non-HLA antigens in breast cancer. Prog Clin Biol Res (1983) 0.75